Home›Stock Screener›Abbott

Abbott Share Price Today | Stock Price & Abbott Share Screener

ABBOTINDIA Pharmaceuticals
Live Share Price NSE
₹25680.00
▼ -225.00 (-0.87%)
2026-10-21 00:00:00
Live Share Price BSE
₹25744.40
▼ -96.35 (-0.37%)
2026-10-21 00:00:00

As of October 21, 2026, the live Abbott share price (NSE: ABBOTINDIA) is ₹25,680.00 on NSE and ₹25,744.40 on BSE, down 0.87% from the previous close, with shares trading between ₹25,135.00 and ₹26,055.00 in today's trading session, and a 52-week range of ₹25,180.00–₹30,205.00. Check ABBOTINDIA annual price range for the annual price range and momentum. Use the Abbott stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Abbott opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹7,295 and net income of ₹1,615, with EBITDA of ₹2,260, an operating margin of 28.0% and a profit margin of 22.1%.

Abbott Market Cap ₹55,609.42 Cr.
ABBOTINDIA P/E Ratio (TTM) 34.31
Abbott P/B Ratio 11.60
EPS (TTM) ₹730.36
Dividend Yield 2.52%
Debt to Equity 0.04
ABBOTINDIA 52 Week High ₹30205.00
Abbott 52 Week Low ₹25180.00
Operating Margin 28.00%
Profit Margin 22.14%
ABBOTINDIA Revenue (TTM) ₹7,295.00
EBITDA ₹2,260.00
Net Income ₹1,615.00
Total Assets ₹6,502.00
Total Equity ₹4,774.00

Abbott Share Price Chart

Track the current stock price of Abbott with an interactive chart. Analyse ABBOTINDIA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Abbott stock quote in one place.

The quote of ₹25,680.00 sits between the 52-week low of ₹25,180.00 and the 52-week high of ₹30,205.00, and the latest session moved -0.87% from the previous close.

Abbott Company Profile - Fundamental Screener

Screen Abbott company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ABBOTINDIA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, with Munir Shaikh listed as chairperson or CEO, and it trades under ISIN INE358A01014.

Business Overview

Abbott India Ltd is a leading multinational pharmaceutical company in India. It operates an owned manufacturing facility in Goa and works with various independent contract manufacturers across the country. The company sells its products primarily within India through independent distributors. Abbott India provides pharmaceutical products and solutions across various therapeutic...more

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

Chairperson/CEO Munir Shaikh
ISIN INE358A01014

Abbott Balance Sheet Screener

Screen ABBOTINDIA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹6,502, up from ₹5,917 in 2025.

Latest statistics put total assets at ₹6,502 and shareholder funds at ₹4,774, with a leverage ratio of 0.04.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 6,502 5,917 5,194 4,556 4,224 3,840 3,547 2,941 2,416 2,066
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 331 336 225 237 271 251 270 105 81 110

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 251 277 152 161 201 207 224 75 55 47
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 4,774 4,233 3,699 3,189 2,820 2,602 2,432 2,009 1,693 1,387
Share Capital 21 21 21 21 21 21 21 21 21 21
Reserves & Surplus 4,753 4,212 3,678 3,167 2,799 2,581 2,411 1,987 1,672 1,366

Abbott Income Statement Screener - Profit & Revenue Analysis

Screen Abbott income statement and profit fundamentals. Analyze ABBOTINDIA quarterly results. Abbott reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹7,295 and net profit was ₹1,615, equal to earnings per unit of ₹759.80, at an operating margin of 28%.

In that period expenses were ₹5,036, interest cost ₹25 and tax ₹557. The next period listed, 2026-March, shows revenue of ₹7,217 and net profit of ₹1,552.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 7,295 7,217 6,685 6,097 5,503 4,997 4,391 4,208 3,792 3,416 2,960 2,665 2,337
Expenses 5,036 5,037 4,715 4,396 4,143 3,832 3,389 3,337 3,074 2,774 2,505 2,250 1,977

Operating Costs and Margins

EBITDA 2,260 2,180 1,970 1,701 1,360 1,165 1,002 871 718 642 455 415 360
Operating Profit % 28.00% 27.00% 26.00% 25.00% 23.00% 22.00% 21.00% 18.00% 16.00% 16.00% 14.00% 14.00% 13.00%
Depreciation 76 76 72 71 70 66 58 60 17 16 16 14 15
Interest 25 25 11 12 16 19 18 9 2 4 2 3 1

Profit and Earnings

Profit Before Tax 2,158 2,079 1,887 1,618 1,274 1,080 926 803 699 622 437 398 344
Tax 557 527 473 417 324 281 235 210 249 220 160 143 115
Net Profit 1,615 1,552 1,414 1,201 949 799 691 593 450 401 277 255 229
EPS 759.80 730.36 665.62 565.28 446.80 375.87 325.04 279.04 211.93 188.81 130.19 120.12 107.75

Abbott Cash Flow Screener - Liquidity Fundamentals

Screen ABBOTINDIA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹1,319, and net cash flow was an outflow of ₹118.

Over the same period, investing activities used ₹371 and financing activities used ₹1,066.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 1,319 1,012 1,213 893 948 727 626 499 153 307
Investing Activities -371 182 -416 -148 -396 -72 -401 -257 -215 -155

Financing and Net Cash

Financing Activities -1,066 -925 -745 -639 -637 -582 -217 -143 -102 -90
Net Cash Flow -118 269 52 107 -86 73 8 99 -165 62

Abbott Shareholding Pattern Screener

See Abbott shareholding pattern with promoter, FII, and DII holdings. Check Abbott promoter holding and ownership changes for ABBOTINDIA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 74.99%, foreign institutions 0.26%, domestic institutions 8.93% and the public 13.38%, spread across 75,866 shareholders.

The shareholder count was 75,866 in 2026-Mar, compared with 78,320 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99%

Institutional Investors

FII Holding 0.26% 0.38% 0.40% 0.16% 0.16% 0.16% 0.18% 0.18%
DII Holding 8.93% 8.78% 8.99% 8.92% 9.19% 9.11% 9.00% 8.91%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 13.38% 13.41% 13.19% 13.66% 13.35% 13.43% 13.42% 13.80%
Other Holding 2.43% 2.44% 2.44% 2.28% 2.31% 2.31% 2.42% 2.12%
Shareholder Count 75,866 78,320 75,769 69,934 67,584 71,199 75,801 69,382

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Abbott. Abbott dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹656.00 per unit for 2026-March, a yield of 2.51%, compared with ₹475.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹656.00, ₹475.00 and ₹410.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹656.00 2.51%
2025-March ₹475.00 1.83%
2024-March ₹410.00 1.33%
2023-March ₹325.00 1.20%
2022-March ₹275.00 1.26%
2021-March ₹275.00 1.55%
2020-March ₹250.00 1.67%
2019-March ₹65.00 0.42%
2018-March ₹55.00 0.75%
2017-March ₹40.00 0.73%

Abbott Stock Index Membership - Nifty & Sensex

See which indices include Abbott stock. Check ABBOTINDIA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 25 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE 200 EQUAL WEIGHT, BSE INDEX BSE HC, BSE INDEX BSE200.

Complete Index List

BSE 1000
BSE 200 EQUAL WEIGHT
BSE INDEX BSE HC
BSE INDEX BSE200
BSE INDEX BSE500
BSE INDEX BSELVI
BSE INDEX BSEQUI
BSE INDEX LMI250
BSE INDEX MID150
BSE INDEX MIDCAP
BSE INDEX MSL400
NIFTY 500
NIFTY HEALTHCARE
NIFTY LARGEMID250
NIFTY M150 QLTY50
NIFTY MIDCAP 150
NIFTY MIDSMALL INDIA CONSUMPTION
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY MNC
NIFTY PHARMA
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP

Abbott Market Events Screener - Corporate Actions

Get Abbott corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Abbott stock events that may affect ABBOTINDIA share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated August 13, 2026, with a record date of August 13, 2026.

It is followed by Quarterly Result Announcement dated August 12, 2026 and Dividend dated July 24, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-08-13 2026-08-13 Annual General Meeting NA 5.57%
2026-08-12 2026-08-12 Quarterly Result Announcement NA 0.45%
2026-07-24 2026-07-24 Dividend ₹ 131.00 /share 7.78%
2026-07-24 2026-07-24 Dividend ₹ 525.00 /share 7.78%
2026-05-11 2026-05-11 Quarterly Result Announcement NA 4.62%
2026-02-12 2026-02-12 Quarterly Result Announcement NA 0.09%
2025-11-06 2025-11-06 Quarterly Result Announcement NA -1.36%
2025-08-13 2025-08-13 Annual General Meeting NA 6.57%
2025-08-12 2025-08-12 Quarterly Result Announcement NA -1.83%
2025-07-25 2025-07-25 Dividend ₹ 475.00 /share 13.94%
2025-05-15 2025-05-15 Quarterly Result Announcement NA 0.67%
2025-02-05 2025-02-05 Quarterly Result Announcement NA -1.42%
2024-11-07 2024-11-07 Quarterly Result Announcement NA 2.06%
2024-08-08 2024-08-08 Annual General Meeting NA 8.45%
2024-07-19 2024-07-19 Dividend ₹ 410.00 /share 10.98%

Abbott Competitors Screener - Peer Stocks Comparison

Screen ABBOTINDIA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 421,995 34.86 61,674 12.69% 11,565 37.01
Divis Laboratories 242,758 82.05 11,067 13.95% 2,568 46.92
Torrent Pharmaceuticals 173,406 81.26 13,886 20.34% 2,138 32.77
Zydus Life Science 112,020 24.78 27,658 17.64% 5,026 44.73
Laurus Labs 111,310 100.10 6,868 22.01% 890 60.45
Cipla 107,049 32.11 29,045 2.24% 3,870 40.32
Dr Reddys Laboratories 102,916 32.01 35,059 3.90% 4,158 57.84
Aurobindo Pharma 95,910 25.97 34,145 5.56% 3,503 47.98
Mankind Pharma 93,988 47.04 14,636 14.85% 1,938 37.77
Lupin 89,702 16.14 29,039 26.75% 5,356 35.35

Abbott Company Announcements - News & Reports Screener

Screen ABBOTINDIA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 6, 2026.

The next most recent announcements are dated October 2, 2026 and September 28, 2026.

Date Update Actions
2026-10-06 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-02 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-28 Closure of Trading Window -
2026-09-07 Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer -
2026-08-14 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-08-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-13 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-12 Unaudited Financial Results For The Quarter Ended June 30 2026. -
2026-08-12 Board Meeting Outcome for Outcome Of Board Meeting -
2026-08-04 Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter Ended June 30 2026. -
2026-08-04 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-20 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-20 Communication Providing The Weblink Including Path Of Annual Report. -
2026-07-20 Business Responsibility and Sustainability Reporting (BRSR) -
2026-07-20 Annual General Meeting On August 13 2026. -
2026-07-20 Reg. 34 (1) Annual Report. -
2026-07-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-26 Closure of Trading Window -
2026-06-17 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2026-06-15 Communication To Shareholders - Intimation About Tax Deduction At Source On Dividend -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹25,680.00, within a 52-week range of ₹25,180.00 to ₹30,205.00. The P/E ratio is 34.31 and the P/B ratio is 11.60, with earnings per unit of ₹730.36. Market capitalisation stands at ₹55,609.42 Cr and the dividend yield is 2.52%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 22, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.